Loading
₹360.00
−9.10−2.47%today
Market closed · 7 Oct, 3:30 pm
+3.55%over 5 years
Today's range
₹358.40₹368.40
52-week range
₹337.70₹447.15
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 16,780 | 386 | 2.3% | 2.82 |
| FY25 | 15,052 | 1,013 | 6.7% | 8.46 |
| FY24 | 14,196 | 1,023 | 7.2% | 8.54 |
| FY23 | 10,934 | 463 | 4.2% | 3.87 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 44.68% | 44.91% | 54.45% | 54.45% |
| FIIs | 8.14% | 7.52% | 7.39% | 6.61% |
| DIIs | 23.38% | 24.07% | 21.71% | 22.10% |
| of which mutual funds | 15.47% | 16.53% | 13.75% | 14.13% |
| Government | n/a | n/a | 0.00% | n/a |
| Public | 23.75% | 23.41% | 16.33% | 16.69% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Glenmark Pharmaceuticals Ltd.GLENMARK | 2,282.30 | −1.24% | 64,412 |
| Alkem Laboratories Ltd.ALKEM | 5,350.50 | +1.11% | 63,973 |
| Aster DM Quality Care Ltd.ASTERDM | 680.10 | −0.67% | 59,282 |
| Fortis Healthcare Ltd.FORTIS | 779.10 | +1.98% | 58,819 |
| Biocon Ltd.BIOCON · this stock | 360.00 | −2.47% | 58,669 |
| Abbott India Ltd.ABBOTINDIA | 26,100.00 | −0.06% | 55,461 |
| Gland Pharma Ltd.GLAND | 3,159.00 | +5.09% | 52,127 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.